iTeos Therapeutics, Inc.
ITOS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$134 | -$113 | $97 | $215 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | -$3 | $0 | $0 |
| Stock-Based Comp. | $30 | $27 | $22 | $14 |
| Change in WC | $19 | -$9 | -$228 | $284 |
| Other Non-Cash | -$14 | -$7 | -$2 | $0 |
| Operating Cash Flow | -$98 | -$104 | -$111 | $513 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$3 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$521 | -$291 | -$445 | $0 |
| Inv. Sales/Matur. | $391 | $366 | $0 | $0 |
| Other Inv. Act. | -$0 | -$0 | -$0 | -$0 |
| Investing Cash Flow | -$131 | $73 | -$446 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $120 | $1 | $1 | $3 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $0 | $1 | $1 |
| Financing Cash Flow | $122 | $1 | $2 | $4 |
| Forex Effect | -$2 | -$4 | -$9 | -$3 |
| Net Chg. in Cash | -$109 | -$34 | -$564 | $512 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $251 | $285 | $849 | $336 |
| End Cash | $142 | $251 | $285 | $849 |
| Free Cash Flow | -$100 | -$107 | -$112 | $512 |